Opportunity

DIBBS #SPE2DP-26-T-3064

DLA Solicitation for Ceftriaxone Injection, 1g (25 Vials) – Fort Hood Delivery

Posted

April 24, 2026

Respond By

April 29, 2026

Identifier

SPE2DP-26-T-3064

NAICS

325412, 424210

This procurement opportunity from the Defense Logistics Agency (DLA) seeks supply of Ceftriaxone Injection for military medical use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Buyer: Patrell Postell, Buyer Code DPP0028 - OEMs (Original Equipment Manufacturers): - Hikma Pharmaceuticals USA Inc. (NDC00143-9857-25) - Sagent Pharmaceuticals, Inc (NDC25021-0106-10) - WG Critical Care, LLC (NDC44567-0701-25) - Vendors: Same as OEMs (no resellers specified) - Product Requested: - Ceftriaxone Injection, USP, 1 gram strength - NSN: 6505-01-554-4282 - Packaged as 25 single-use vials per package - Quantity: 1 package - Shelf life: 24 months (minimum 21 months at receipt) - Storage: 20 to 25°C, protect from light - Labeling: Medical Marking Standard No. 1, hazardous material labeling - Notable Requirements: - Delivery required within 20 days to Fort Hood, TX - Compliance with domestic sourcing laws - Cybersecurity requirements apply - Delivery Location: - Fort Hood, TX (BLDG 40054 MOTOR POOL ROAD, 76544) - Solicitation accessible via DIBBS portal

Description

CEFTRIAXONE INJECTI (QTY: 1, NSN: 6505-01-554-4282, Purchase Request: 7016481146) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC

View original listing